We spoke with Dr. V. Vasu Kakarlapudi, primary investigator of the published 2-year pivotal RhinAer study. We discussed the common frustrations experienced by many of his chronic rhinitis patients, why he chooses RhinAer for his patients, and key implications of the new RhinAer study results.
Read the full Q&A here.
